David Wayne Magnusson David Wayne Magnusson, 72, passed away peacefully on Dec. 13, 2024 due to complications of Parkinson’s disease. He was diagnosed ...

Beta-blockers are linked to delayed motor decline in premanifest Huntington disease and reduced symptom progression in early ...

HealthDay News — β-blocker use is associated with delayed motor onset and worsening of motor symptoms with Huntington disease (HD), according to a study published online Dec. 2 in JAMA Neurology.

Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase I for Parkinson's Disease.

Shrinking' co-creator Bill Lawrence recently revealed how Michael J Fox's battle with Parkinson's shaped the portrayal of the ...

Now, the show’s co-creator, Bill Lawrence, has opened up about how they depict the disease on the comedy and how his ...

Shrinking cocreator Bill Lawrence revealed Michael J. Fox had a hand in shaping the show’s portrayal of Parkinson’s disease. “It’s cool to get to write about things you care about now,” Lawrence, 56, ...

Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 148,600 shares, ...

Researchers at the University of Illinois have found that a gene editing tool allows them to “skip” genes that lead to ...

The global neuro immunoassay market is projected to experience significant growth, with a valuation of US$ 2,616.1 million in ...

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease.

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce ...